• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Distinct Proteomic Profiles after Transfusion with Plasma vs. Whole Blood among Trauma Patients

April 8, 2025

Early blood product transfusion is important for optimal trauma care, but it is not well understood how different blood products affect coagulopathy and the immune response.  Recently, several studies have suggested that whole blood administered early may be associated with improved survival, but other studies suggest that treatment effects may vary based on patient demographics and the type of injury. To compare the effects of early plasma transfusion with low-titer O whole blood (LTOWB), researchers followed a cohort (n=134; median age, 34 years; 64% male; 38% penetrating injury) of trauma patients with hemorrhagic shock from the Shock, Whole Blood and Assessment of Traumatic Brain Injury multicenter, observational study (n=1051). Based on a proteomic analysis of 198 proteins (central to inflammatory and hemostatic processes) at hospital admission and 4-and 24-hours later, trauma patients who received plasma (with or without LTOWB) had distinct patterns compared to those who did not receive any plasma. Notably, patients who received plasma had higher levels of fibrinogen and plasmin, lower levels of platelet factor 4, shorter international normalized ratio (INR), improved prothrombin times, and lower overall transfusion volumes over 24 hours compared to patients who did not receive plasma. Randomized controlled trials are needed to further understand the clinical implications of plasma and LTOWB for different subgroups of trauma patients.

Reference:

Moheimani H, Sun X, Ozel M, Darby JL, et al.  High-dimensional analysis of injured patients reveals distinct circulating proteomic profiles in plasma vs. whole blood resuscitation. Cell Reports Medicine 2025; 6(3)

Filed Under

  • Uncategorized

Recommended

  • Serosurveillance of SARS-CoV-2 from Blood Donations across the U.S.

  • Recurrence of ABO Blood Groups Stems From Trans-Species Polymorphism

  • Impact of Implementation of Individual Donor Assessment

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Directed Blood Donations Should be Limited

  • Babesia Infection Reduces Red Cell Deformability

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley